Skip to content
    Inve.money
    Earnings calls

    Viyash Scientific Limited concall ledger

    Every earnings call for VIYASH — management tone, guidance, KPIs and promise tracking, quarter by quarter.

    VIYASH · 5 transcripts · Healthcare · latest Q4 FY26

    Viyash Scientific Limited has 5 earnings calls on record here, a Healthcare company, most recently Q4 FY26. Each quarter is scored on revenue, margins, guidance delivery and the questions management left unanswered — so the gap between what was promised and what was delivered is easy to read.

    Q4 FY26Published 20 May 2026Call held 20 May 2026

    VIYASH Q4 FY26 Earnings Call Transcript & Analysis

    Total Revenue₹920 cr+19% YoYAdjusted EBITDA₹200 cr+64% YoYEBITDA Margin21.7%PAT₹66 cr

    Total Revenue (Q4 FY26) ₹920 cr (+19% YoY); Adjusted EBITDA (Q4 FY26) ₹200 cr (+64% YoY); EBITDA Margin (Q4 FY26) 21.7%. Q4 FY26 EBITDA surpassed INR200 crores, with FY26 EBITDA up 59.6% to INR702 crores.

    Read full transcript & analysis
    Q1 FY26Published 11 Aug 2025Call held 11 Aug 2025

    VIYASH Q1 FY26 Earnings Call Transcript & Analysis

    Viyash Revenue₹353 cr+4% YoYViyash Adjusted EBITDA₹68 cr+19% YoYViyash EBITDA Margin19.5%+2% YoYCombined Revenue Growth—+9% YoYCombined Adjusted EBITDA Growth—+21% YoY

    Viyash Revenue ₹353 cr (+4% YoY); Viyash Adjusted EBITDA ₹68 cr (+19% YoY); Viyash EBITDA Margin 19.5% (+2% YoY). Viyash revenue grew by 4% YoY to INR353 crores.

    Read full transcript & analysis
    Q4 FY25Published 21 May 2025Call held 21 May 2025

    VIYASH Q4 FY25 Earnings Call Transcript & Analysis

    Viyash Q4 Revenue₹370 cr+15% YoYViyash Q4 Adj. EBITDA₹65.3 cr+93% YoYViyash Q4 EBITDA Margin17.6%Viyash FY25 Revenue₹1,458 cr+11% YoYViyash FY25 Adj. EBITDA₹254.6 cr+52% YoY

    Viyash Q4 Revenue ₹370 cr (+15% YoY); Viyash Q4 Adj. EBITDA ₹65 cr (+93% YoY); Viyash Q4 EBITDA Margin 17.6%. Viyash Q4 FY25 revenue grew 15% YoY to ₹370 crores.

    Read full transcript & analysis